Pentapeptide-18 (Leuphasyl)
Pentapeptide-18 (Leuphasyl) is a topical peptide that reduces muscle signaling to relax expression lines and improve the smoothness of the skin
Pentapeptide-18, marketed as Leuphasyl, is a five-amino-acid peptide that gently suppresses muscle contractions causing expression lines by inhibiting acetylcholine release at the neuromuscular junction—mimicking Botox’s mechanism but topically and non-invasively. Clinical studies show 11-12% reduction in wrinkle depth, enhanced collagen and elastin production, and reduced glutamate release supporting overall facial expression smoothing while preserving natural movement unlike frozen-appearance Botox injections.
Key advantages include complete safety profile without neurological side effects, preserved facial expressions and natural appearance, synergistic effects when combined with other peptides (particularly Argireline which targets different neural pathways), and potential melanin suppression in D-tyrosine-containing analogs supporting skin brightening. Research confirms 2-4 weeks needed for visible wrinkle reduction with 4% concentration, and potent effects at 2% strength without irritation. Ideal for anyone seeking Botox-like wrinkle reduction without injections, paralysis risk, or maintenance appointments, Pentapeptide-18 offers a gentle topical alternative for dynamic wrinkle prevention and softening.
Pentapeptide-18 (Leuphasyl) – Benefits & Side Effects
Pentapeptide-18 (Leuphasyl) – Protocol
Pentapeptide-18 (Leuphasyl)
Research Goal: Analyzing the inhibition of calcium influx across the neuron membrane to reduce glutamate release and muscle contraction.
Preparation: Typically used as a topical solution (3%–10%). Often combined with Argireline for synergistic effects on the SNARE complex.
Application Schedule (Topical)
| Target | Concentration | Frequency |
|---|---|---|
| Expression Lines | 5% Solution | Twice Daily |
| Intensive Repair | 10% Solution | Once Daily (Night) |
- Frequency: 1–2 times daily.
- Timing: Apply to clean skin, specifically on the forehead and around the eyes.
- Cycle Length: 28–60 days for measurable depth reduction.
Pentapeptide-18 (Leuphasyl) – Lifestyle Considerations
Proper Peptide Storage
Why Proper Peptide Storage Matters
Peptides are delicate molecules sensitive to temperature, moisture, light, and repeated freeze-thaw cycles. Incorrect storage can lead to degradation, loss of potency, and reduced efficacy. Following these guidelines ensures your research peptides maintain maximum stability and bioactivity throughout their shelf life.
Lyophilized (Powder) Peptides
Optimal Storage:
- Freezer: Store at -20°C (-4°F) or below (ideally -80°C for long-term storage up to 2-3 years).
- Short-term: Refrigerate at 2-8°C (35.6-46.4°F) for weeks to months.
- Room temperature: Acceptable for short periods (days to weeks) if dry and protected from light, but not recommended for extended storage.
- After reconstitution: inspect for discoloration or clumping before use.
Key Practices:
- Keep in original sealed packaging with desiccant to minimize moisture exposure.
- Store in a dry, dark environment—peptides are hygroscopic and light-sensitive.
- Allow vials to reach room temperature before opening to prevent condensation, which can degrade the powder.
Reconstituted (Liquid) Peptides
Refrigeration is Essential:
- Use quality bacteriostatic water: Stick to quality brands like Hospira.
- Store at 2-8°C (35.6-46.4°F) immediately after reconstitution.
- Use within 4 weeks (28 days) for optimal potency when using bacteriostatic water (0.9% benzyl alcohol).
- Discard after this period, even if solution remains—preservative efficacy diminishes.
Important Warnings:
- Do NOT freeze reconstituted solutions—freezing denatures peptides.
- Avoid freeze-thaw cycles—they cause irreversible degradation. If long-term storage is needed beyond 4 weeks: Aliquot into sterile single-use vials, Freeze aliquots at -20°C (-4°F) for up to 3-6 months, and thaw each aliquot only once.
Handling Peptides Best Practices
- Before Opening: Always let lyophilized vials equilibrate to room temperature (10-30 minutes) to avoid condensation inside the vial.
- Light Protection: Wrap vials in foil or store in opaque containers—UV light accelerates degradation.
- Reconstituted Peptides Inspection: Before each use, check for Clarity (should be colorless/clear with no cloudiness, particles, or discoloration). Discard if any issues observed.
- Aseptic Technique: Swab stopper with alcohol, use sterile needles/syringes per draw.
- Labeling: Mark reconstitution date on vials.
Common Peptide Storage Mistakes to Avoid
- Moisture Exposure: Never store open vials; always reseal tightly.
- Temperature Fluctuations: Avoid door storage in fridge/freezer.
- Heat/Light: Keep away from direct sunlight, heaters, or lab lights.
- Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
- Freezing Liquids: Repeated cycles can reduce potency by 25%+ per cycle.
Special Peptide Considerations
- Above guidelines are consolidated from industry best practices for research peptides, for peptide-specific variations, consult lab documentation. Examples below highlight how specialized peptides can differ:
- HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).
- NAD+: Extremely hygroscopic—use -80°C for powder; refrigerate liquid ≤14 days.
- PT-141: Room temp stable short-term; refrigerate reconstituted ≤1 week.
Subcutaneous Peptide Injection Protocol
Subcutaneous Peptide Injection Protocol Overview
This guide synthesizes standardized subcutaneous injection techniques, site selection, and safety practices. Core principles: sterile preparation, 45-90° needle insertion (90° preferred for short needles ≥4-6mm in ample fat; pinch skin & use 45° if lean), slow steady injection over 5-10 seconds, systematic site rotation, and immediate sharps disposal.
Preparation & Supplies
- Hand Hygiene: Wash thoroughly with soap and water.
- Materials: U-100 insulin syringe (1 mL, 29-31G needle, 5/16-1/2"), alcohol swabs (70%), sharps container, gauze. Use 30-50 unit syringes for volumes <10 units.
- Vial Prep: Wipe stopper, dry 10-30 seconds, draw dose, tap out air bubbles. Warm vials to room temperature to reduce stinging.
- Volume Limit: ≤1.5 mL per site; split larger doses (e.g., 75 IU into 3x25 IU). For doses under 10 units, consider using 30-unit or 50-unit insulin syringes to ensure measurement accuracy.
Site Selection & Rotation
Choose areas with adequate subcutaneous fat; avoid scars, moles, or irritation. Systematically rotate sites 1-1.5 inches apart; avoid same spot for 1-2 weeks. Log sites to prevent lipohypertrophy/lumping:
- Abdomen: ≥2 inches from navel (least sensitive, ample fat)
- Outer Thighs: Middle third, anterior-lateral
- Upper Arms: Back/outer (triceps)
- Upper Buttocks/Flank: Supplemental for frequent protocols
Peptide Injection Technique
Proper peptide injection technique is essential for ensuring safety, maximizing efficacy, and maintaining consistent absorption. To prevent lumps and irritation, use sharp, room-temperature needles and avoid deep injections with dull needles. Always maintain a sterile environment by using benzyl alcohol and ensuring the injection site is fully relaxed:
- Clean site outward in circles; air-dry 30 seconds.
- Pinch 1-2 inch skin fold to lift subcutaneous layer.
- Insert needle at 45-90° angle (90° for ample fat, 45° for lean/thin needle).
- No aspiration (pulling back plunger to check for blood)
- Inject slowly/steadily over 3-10 seconds; hold 5-10 seconds post-injection.
- Withdraw at same angle; gentle pressure if bleeding.
- Dispose in sharps container immediately; never recap.
- Discard any reconstituted solution if it becomes cloudy. Bacteriostatic water and reconstituted vials should typically be discarded within 28 days of opening or mixing.
Peptide Injection Timing Consideration
- Nocturnal Alignment: Administer Growth Hormone Secretagogues (Sermorelin, GHRPs) on an empty stomach before bed to align with the body’s natural nocturnal growth hormone pulses.
- Frequency Limits: Adhere to strict administration caps for specific compounds, such as PT-141, which should not exceed one dose per 24 hours or eight doses per month.
- Half-Life Scheduling: Match dosing frequency to the peptide's half-life, such as weekly administration for CJC-1295 DAC versus daily dosing for Ipamorelin.
- Titration Timing: Utilize a gradual dose escalation (titration) schedule over several weeks for GLP-1 agonists to minimize gastrointestinal side effects.
- Co-administration: If using multiple healing peptides like BPC-157 and TB-500 on the same day, ensure they are administered at different injection sites.
- Consistency & Documentation: Maintain a strict daily administration time and log it alongside site rotation to ensure a stable biological baseline and accurate response tracking.
Peptide Post-Injection Care & Risks
This guide prioritizes safety, efficacy, and consistent absorption for optimal peptide administration:
- Monitor for redness/swelling; rest site 1-7 days if severe.
- No massage (disrupts absorption).
- Document dose, site, time, reactions.
- Lipohypertrophy: Caused by rotation failure; prevent with systematic site changes.
- Pain/Lumps: From deep injection, cold solution, or dull needles.
- Infection: Maintain asepsis; monitor for fever/redness.
Pentapeptide-18 (Leuphasyl) – Identification
Common Names: Pentapeptide-18, Leuphasyl®, [D-Ala²]Leucine-enkephalin, (D-Ala²)Leu⁵-Enkephalin, D-Ala²-Leu⁵-Enkephalin
CAS Number: 64963-01-5 (primary)
Molecular Formula: C₂₉H₃₉N₅O₇
Molecular Weight: 569.65-569.7 g/mol
Origin & Type Classification:
-
Source: Synthetic; engineered variant of naturally occurring enkephalin neuropeptides
-
Biosynthesis: Non-ribosomal; chemically synthesized via solid-phase peptide synthesis (SPPS)
-
Functional Class: Enkephalin-like neuropeptide; neurotransmitter modulator; acetylcholine inhibitor; cosmeceutical peptide; anti-wrinkle agent
Additional Information:
-
Amino Acid Sequence: H-Tyr-D-Ala-Gly-Phe-Leu-OH (alternatively abbreviated Tyr-D-Ala-Gly-Phe-Leu or DAGFL with Tyr at N-terminus)
-
Sequence Length: 5 amino acids (pentapeptide)
-
Structural Type: Linear peptide with D-amino acid (D-alanine) at position 2; critical stereochemical modification compared to natural L-amino acid forms
-
D-Alanine Modification: Position 2 D-alanine substitution (rather than L-alanine) dramatically increases metabolic stability and bioavailability while maintaining enkephalin receptor recognition
-
Key Amino Acid Features: Tyrosine (phenolic hydroxyl group, contributes to receptor binding); D-alanine (provides stereochemical selectivity); glycine (flexible hinge); phenylalanine (aromatic, enhances receptor binding); leucine (hydrophobic C-terminal)
-
Opioid Receptor Agonism: Agonist of mu (μ) and delta (δ) opioid receptors, operating through enkephalin receptor-mediated mechanisms
-
Salt Form: Available as free peptide or acetate salt; white to off-white lyophilized powder
-
Melting Point: 160-163.5°C
-
Solubility: Soluble in water; slightly soluble in DMSO and DMF
-
Storage Requirements: Store at -20°C in dark, sealed, dry conditions
-
Known Synonyms: [D-Ala²]Leucine-enkephalin, Leuphasyl (brand name, Lipotec S.A.), D-Ala²-Leu⁵-Enkephalin
-
Supplier Identification: PubChem CID 10099522 (alternative CID 92223068); EINECS 265-291-0; GSRS reference PO4D55T1IG
Database Links:
-
PubChem: CID 10099522 (Pentapeptide-18)
-
UniProt: Not applicable; synthetic engineered neuropeptide
-
PDB: Not applicable
-
NCBI: Accessible through cosmeceutical peptide and anti-wrinkle peptide literature
Important Note: Pentapeptide-18's D-amino acid stereochemistry distinguishes it from natural enkephalins and provides enhanced proteolytic resistance enabling topical cosmeceutical application.
Pentapeptide-18 (Leuphasyl) – Research
Study: Clinical evidence of the efficacy and safety of a new multi-peptide anti-aging eye serum: a randomized split-face study
Benefits: Softens expression lines around eyes and mouth, relaxes muscle twitches without paralysis, boosts skin firmness in weeks.
Link: https://pubmed.ncbi.nlm.nih.gov/37335808/
Summary: Pentapeptide-18 (Leuphasyl) mimics brain signals to chill overactive face muscles causing frown lines or crow's feet, like a milder Botox. In a 28-day trial on 32 young adults, half-face serum with Leuphasyl shrank wrinkles in number, depth, volume—hydration soared, elasticity/firmness climbed steadily. 75% loved smoother look, no side effects. It blocks neurotransmitter release gently, preventing paralysis droop. For 9th graders squinting at phones or smiling big in pics, it smooths "tech neck" lines or giggle creases early, keeps fresh face without needles. Daily dab equals relaxed, youthful vibe—perfect for selfies, braces smiles, school stress grins. Safe, non-invasive youth lock-in.
Study: An Open Label Clinical Trial of a Peptide Treatment Serum and Supporting Skincare Regimen for Facial Photodamage
Benefits: Fades sun wrinkles and rough texture, calms skin nerves for even tone, improves photodamage glow in 14 weeks.
Link: https://pubmed.ncbi.nlm.nih.gov/27602972/
Summary: Leuphasyl in GABA-peptide serum tested on 29 sun-damaged women: visible smoothing, tone evening, photodamage drop. Neuro-inhibiting peptides relaxed tension lines. No issues. Teens post-beach or sports sun get repair boost, prevent permanent etchings.
Study: Prospective randomized clinical study of a new topical formulation containing leuphasyl® for the treatment of facial wrinkles
Benefits: Prolongs Botox effects, regenerates dermis deep, cuts superficial lines safely.
Link: https://pubmed.ncbi.nlm.nih.gov/33453095/
Summary: Randomized trial: Leuphasyl topical extended toxin results, dermal rebuild, wrinkle shrink. Safe synergy. Alternative/adder for smooth skin.
Study: Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin
Benefits: Stimulates collagen for line fill, sun damage reversal, texture smooth.
Link: https://pubmed.ncbi.nlm.nih.gov/18492182/
Summary: Cousin peptide pal-KTTKS slashed wrinkles 80% self-report. Leuphasyl similar muscle relax + build. Youth serum power.
Pentapeptide-18 (Leuphasyl) – Research Links
Dosing Highlights
- Pentapeptide-18, marketed as Leuphasyl, is a five-amino-acid peptide that gently suppresses muscle contractions causing expression lines by inhibiting acetylcholine release at the neuromuscular juncti…
- Key advantages include complete safety profile without neurological side effects, preserved facial expressions and natural appearance, synergistic effects when combined with other peptides (particular…
- Protocol
- Injection Procotol
- Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
- HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).